Intracavernous Injection of Platelet-Rich Plasma Reverses Erectile Dysfunction of Chronic Cavernous Nerve Degeneration Through Reduction of Prostate Hyperplasia: Evidence From an Aging-Induced Erectile Dysfunction Rat Model
March 2023
in “
The FASEB Journal
”
TLDR Platelet-rich plasma can improve erectile function in older individuals by reducing prostate enlargement.
The study examined the impact of intracavernous platelet-rich plasma (PRP) injections on erectile dysfunction (ED) and prostate hyperplasia in an aging-induced ED rat model, involving 30 male Sprague-Dawley rats. PRP treatment improved erectile function by increasing intracavernous pressure and reducing prostate gland volume, indicating a decrease in prostate hyperplasia. The therapy also promoted nerve regeneration and tissue repair, suggesting that PRP could be a promising, cost-effective treatment for aging-associated ED and prostate hyperplasia.